Stockysis — AI-Powered Stock News & Sentiment Analysis

B. Riley Securities Reiterates Buy on OptimizeRx, Lowers Price Target to $11

Benzinga Newsdesk www.benzinga.com Negative 86.9%

Neg 86.9% Neu 0% Pos 0%

B. Riley Securities analyst Anderson Schock reiterates OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $28 to $11.

Comments

No comments yet. Be the first!